165 related articles for article (PubMed ID: 7695232)
1. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
[TBL] [Abstract][Full Text] [Related]
2. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients.
Richfield EK; Maguire-Zeiss KA; Vonkeman HE; Voorn P
Ann Neurol; 1995 Dec; 38(6):852-61. PubMed ID: 8526457
[TBL] [Abstract][Full Text] [Related]
3. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
4. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
Richfield EK; Herkenham M
Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
[TBL] [Abstract][Full Text] [Related]
5. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
6. Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.
Sun Z; Del Mar N; Meade C; Goldowitz D; Reiner A
Neurobiol Dis; 2002 Dec; 11(3):369-85. PubMed ID: 12586547
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys.
Bezard E; Ravenscroft P; Gross CE; Crossman AR; Brotchie JM
Neurobiol Dis; 2001 Apr; 8(2):343-50. PubMed ID: 11300729
[TBL] [Abstract][Full Text] [Related]
8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
9. Postnatal development of preproenkephalin mRNA containing neurons in the rat lower brainstem.
Morita Y; Zhang JH; Hironaka T; Tateno E; Noguchi K; Sato M; Kiyama H; Tohyama M
J Comp Neurol; 1990 Feb; 292(2):193-213. PubMed ID: 2319009
[TBL] [Abstract][Full Text] [Related]
10. Paucity of enkephalin production in neostriatal striosomal neurons: analysis with preproenkephalin-green fluorescent protein transgenic mice.
Koshimizu Y; Wu SX; Unzai T; Hioki H; Sonomura T; Nakamura KC; Fujiyama F; Kaneko T
Eur J Neurosci; 2008 Nov; 28(10):2053-64. PubMed ID: 19046386
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
12. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
13. Distribution of preproenkephalin mRNA in the chicken and pigeon telencephalon.
Molnar M; Casini G; Davis BM; Bagnoli P; Brecha NC
J Comp Neurol; 1994 Oct; 348(3):419-32. PubMed ID: 7844256
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
Augood SJ; Faull RL; Emson PC
Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum.
Campbell K; Björklund A
Eur J Neurosci; 1994 Aug; 6(8):1371-83. PubMed ID: 7981878
[TBL] [Abstract][Full Text] [Related]
16. Fos-enkephalin signaling in the rat medial vestibular nucleus facilitates vestibular compensation.
Kitahara T; Kaneko T; Horii A; Fukushima M; Kizawa-Okumura K; Takeda N; Kubo T
J Neurosci Res; 2006 Jun; 83(8):1573-83. PubMed ID: 16547969
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease.
Richfield EK; Vonsattel JP; MacDonald ME; Sun Z; Deng YP; Reiner A
Mov Disord; 2002 Mar; 17(2):327-32. PubMed ID: 11921119
[TBL] [Abstract][Full Text] [Related]
18. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
[TBL] [Abstract][Full Text] [Related]
19. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.
Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL
Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136
[TBL] [Abstract][Full Text] [Related]
20. [Electroacupuncture enhances enkephalin mRNA expression in the spinal cord and medulla, an in situ hybridization study].
Ji RR; Zhang Q; Han JS
Sheng Li Xue Bao; 1993 Aug; 45(4):395-9. PubMed ID: 8296216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
